Silencing of Vav1 resulted in the increased expression in Akt1 in ER+ cells and in the up-modulation of Akt2 in ER- breast tumor cells, including those with a triple negative phenotype [20], still representing the most aggressive breast cancer [1]. This evidence concerns the gene AKT2 and breast carcinoma.